Patient Access Conference Calls for Change Management Plan to Meet 180-Day Reimbursement Target
Stakeholders at the AXIS Patient Access Conference in Dublin heard that Ireland must agree a clear operational roadmap to meet its 180-day reimbursement decision target.
Clinical Features
Emergency Pain Relief Inhaler Now Licensed for Children in Ireland
Penthrox (methoxyflurane) is now licensed for use in children aged six and over in Ireland, expanding emergency trauma pain relief options in hospital and pre-hospital settings.
Hospital Pharmacy
Minister Announces New Framework Agreements on Supply and Pricing of Medicines
The Government has finalised new framework agreements with Medicines for Ireland and the Irish Pharmaceutical Healthcare Association to improve access to medicines and strengthen supply security.
Product News
DARZALEX® Becomes First Oncology Injectable Approved for Self-Administration in Europe
Johnson & Johnson has announced European approval for eligible multiple myeloma patients or caregivers to self-administer DARZALEX® from the fifth dose onwards.
